Annual SG&A:
$237.31M+$128.61M(+118.32%)Summary
- As of today, TARS annual SG&A is $237.31 million, with the most recent change of +$128.61 million (+118.32%) on December 31, 2024.
- During the last 3 years, TARS annual SG&A has risen by +$211.91 million (+834.40%).
- TARS annual SG&A is now at all-time high.
Performance
TARS SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly SG&A:
$103.01M+$18.02M(+21.20%)Summary
- As of today, TARS quarterly SG&A is $103.01 million, with the most recent change of +$18.02 million (+21.20%) on June 30, 2025.
- Over the past year, TARS quarterly SG&A has increased by +$44.22 million (+75.22%).
- TARS quarterly SG&A is now at all-time high.
Performance
TARS Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SG&A:
-$1.49B-$91.99M(-6.59%)Summary
- As of today, TARS TTM SG&A is -$1.49 billion, with the most recent change of -$91.99 million (-6.59%) on June 30, 2025.
- Over the past year, TARS TTM SG&A has dropped by -$1.67 billion (-910.19%).
- TARS TTM SG&A is now -24565.35% below its all-time high of -$6.03 million.
Performance
TARS TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, General & Administrative Expenses Formula
SG&A = Total Operating Expenses - Cost of Goods Sold - Research & Development
TARS Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +118.3% | +75.2% | -910.2% |
| 3Y3 Years | +834.4% | +892.8% | -4785.4% |
| 5Y5 Years | +10000.0% | +6650.5% | -10000.0% |
TARS Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +834.4% | at high | +758.9% | -428.9% | at low |
| 5Y | 5-Year | at high | >+9999.0% | at high | +4691.3% | -3750.3% | at low |
| All-Time | All-Time | at high | >+9999.0% | at high | >+9999.0% | >-9999.0% | at low |
TARS Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $103.01M(+21.2%) | $314.95M(+16.3%) |
| Mar 2025 | - | $85.00M(+23.1%) | $270.73M(+14.1%) |
| Dec 2024 | $237.31M(+118.3%) | $69.03M(+19.2%) | $237.31M(+12.3%) |
| Sep 2024 | - | $57.91M(-1.5%) | $211.28M(+15.0%) |
| Jun 2024 | - | $58.79M(+14.0%) | $183.70M(+26.5%) |
| Mar 2024 | - | $51.58M(+19.9%) | $145.18M(+33.6%) |
| Dec 2023 | $108.70M(+141.8%) | $43.01M(+41.8%) | $108.70M(+35.3%) |
| Sep 2023 | - | $30.32M(+49.6%) | $80.33M(+29.6%) |
| Jun 2023 | - | $20.27M(+34.3%) | $62.00M(+19.0%) |
| Mar 2023 | - | $15.10M(+3.2%) | $52.10M(+15.9%) |
| Dec 2022 | $44.95M | $14.63M(+22.0%) | $44.95M(+21.2%) |
| Sep 2022 | - | $11.99M(+15.6%) | $37.09M(+16.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | $10.38M(+30.6%) | $31.77M(+12.7%) |
| Mar 2022 | - | $7.95M(+17.3%) | $28.18M(+11.0%) |
| Dec 2021 | $25.40M(+210.8%) | $6.77M(+1.5%) | $25.40M(+12.8%) |
| Sep 2021 | - | $6.67M(-1.8%) | $22.52M(+25.1%) |
| Jun 2021 | - | $6.79M(+31.7%) | $17.99M(+41.4%) |
| Mar 2021 | - | $5.16M(+32.6%) | $12.73M(+55.7%) |
| Dec 2020 | $8.17M(+619.4%) | $3.89M(+80.9%) | $8.17M(+75.0%) |
| Sep 2020 | - | $2.15M(+40.9%) | $4.67M(+69.6%) |
| Jun 2020 | - | $1.53M(+151.8%) | $2.75M(+124.4%) |
| Mar 2020 | - | $606.00K(+56.6%) | $1.23M(+97.6%) |
| Dec 2019 | $1.14M(+153.0%) | $387.00K(+65.4%) | $621.00K(+165.4%) |
| Sep 2019 | - | $234.00K | $234.00K |
| Dec 2018 | $449.00K | - | - |
FAQ
- What is Tarsus Pharmaceuticals, Inc. annual SG&A?
- What is the all-time high annual SG&A for Tarsus Pharmaceuticals, Inc.?
- What is Tarsus Pharmaceuticals, Inc. annual SG&A year-on-year change?
- What is Tarsus Pharmaceuticals, Inc. quarterly SG&A?
- What is the all-time high quarterly SG&A for Tarsus Pharmaceuticals, Inc.?
- What is Tarsus Pharmaceuticals, Inc. quarterly SG&A year-on-year change?
- What is Tarsus Pharmaceuticals, Inc. TTM SG&A?
- What is the all-time high TTM SG&A for Tarsus Pharmaceuticals, Inc.?
- What is Tarsus Pharmaceuticals, Inc. TTM SG&A year-on-year change?
What is Tarsus Pharmaceuticals, Inc. annual SG&A?
The current annual SG&A of TARS is $237.31M
What is the all-time high annual SG&A for Tarsus Pharmaceuticals, Inc.?
Tarsus Pharmaceuticals, Inc. all-time high annual SG&A is $237.31M
What is Tarsus Pharmaceuticals, Inc. annual SG&A year-on-year change?
Over the past year, TARS annual SG&A has changed by +$128.61M (+118.32%)
What is Tarsus Pharmaceuticals, Inc. quarterly SG&A?
The current quarterly SG&A of TARS is $103.01M
What is the all-time high quarterly SG&A for Tarsus Pharmaceuticals, Inc.?
Tarsus Pharmaceuticals, Inc. all-time high quarterly SG&A is $103.01M
What is Tarsus Pharmaceuticals, Inc. quarterly SG&A year-on-year change?
Over the past year, TARS quarterly SG&A has changed by +$44.22M (+75.22%)
What is Tarsus Pharmaceuticals, Inc. TTM SG&A?
The current TTM SG&A of TARS is -$1.49B
What is the all-time high TTM SG&A for Tarsus Pharmaceuticals, Inc.?
Tarsus Pharmaceuticals, Inc. all-time high TTM SG&A is -$6.03M
What is Tarsus Pharmaceuticals, Inc. TTM SG&A year-on-year change?
Over the past year, TARS TTM SG&A has changed by -$1.67B (-910.19%)